TY - JOUR
T1 - Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2
AU - Yi, Minkyung
AU - Nakamoto, Yasunari
AU - Kaneko, Shuichi
AU - Yamashita, Tatsuya
AU - Murakami, Seishi
N1 - Funding Information:
We thank M. Honda and K. Kobayashi (1st Internal Medicine, Kana-zawa University) for providing the HCV JK1 clone used in this study and for their encouraging support. We also thank C. Matsushima and F. Momoshima for their technical assistance. This work was partly supported by a grant-in-aid for scientific research from the Ministry of Health and Welfare, Japan.
PY - 1997/4/28
Y1 - 1997/4/28
N2 - Hepatitis C virus (HCV) is the major causative agent of blood-borne non-A non-B hepatitis. The persistence of HCV infection is believed to reflect escape from the host immunosurveillance system by mutations in hypervariable region 1 (HVR1) of the envelope protein 2 (E2). Two envelope proteins of HCV, E1 and E2, have been reported to form a heteromeric complex but the exact organization of the viral envelope proteins remains uncertain. We examined the interaction of E1 and E2 by far-Western blotting using the bacterial recombinant proteins and also by pull-down assay using mammalian expressed proteins. The major E1-interacting site of E2 was mapped within the N-terminal part of E2 (NCD1) (aa 415 to 500 of the polyprotein). Both HVR 1 and HVR2, located at the N-terminal part of E2, were dispensable for the interaction. Although several discontinuous regions within NCD1 seemed to contribute to the strong binding to E1, the highly conserved amino acid sequences flanking HVR2 had the most significant effect. The amino acid residues 'WHY' from 489 to 491 of E2 played an especially crucial role since the constructs with the internal deletion or substitution of the residues showed severely impaired E1-binding. The N-terminal part of E1 is important for the E2-binding as determined by far-Western blotting using the mammalian- and bacterial-expressed E2 proteins as probes. The mammalian-expressed, glycosylated forms of the E1 and E2 proteins exhibited E1-E2 binding activities similar to those of the bacterial-expressed, nonglycosylated forms in pull-down assays, suggesting that glycosylation is not prerequisite for the heteromeric complex formation of E1 and E2.
AB - Hepatitis C virus (HCV) is the major causative agent of blood-borne non-A non-B hepatitis. The persistence of HCV infection is believed to reflect escape from the host immunosurveillance system by mutations in hypervariable region 1 (HVR1) of the envelope protein 2 (E2). Two envelope proteins of HCV, E1 and E2, have been reported to form a heteromeric complex but the exact organization of the viral envelope proteins remains uncertain. We examined the interaction of E1 and E2 by far-Western blotting using the bacterial recombinant proteins and also by pull-down assay using mammalian expressed proteins. The major E1-interacting site of E2 was mapped within the N-terminal part of E2 (NCD1) (aa 415 to 500 of the polyprotein). Both HVR 1 and HVR2, located at the N-terminal part of E2, were dispensable for the interaction. Although several discontinuous regions within NCD1 seemed to contribute to the strong binding to E1, the highly conserved amino acid sequences flanking HVR2 had the most significant effect. The amino acid residues 'WHY' from 489 to 491 of E2 played an especially crucial role since the constructs with the internal deletion or substitution of the residues showed severely impaired E1-binding. The N-terminal part of E1 is important for the E2-binding as determined by far-Western blotting using the mammalian- and bacterial-expressed E2 proteins as probes. The mammalian-expressed, glycosylated forms of the E1 and E2 proteins exhibited E1-E2 binding activities similar to those of the bacterial-expressed, nonglycosylated forms in pull-down assays, suggesting that glycosylation is not prerequisite for the heteromeric complex formation of E1 and E2.
UR - http://www.scopus.com/inward/record.url?scp=0030981230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030981230&partnerID=8YFLogxK
U2 - 10.1006/viro.1997.8516
DO - 10.1006/viro.1997.8516
M3 - Article
C2 - 9143310
AN - SCOPUS:0030981230
SN - 0042-6822
VL - 231
SP - 119
EP - 129
JO - Virology
JF - Virology
IS - 1
ER -